Michel Vounatsos, Biogen CEO (via YouTube)
June 18, 2020 10:29 AM EDT
Pharma

In a fresh blow, Bio­gen los­es a big court fight with My­lan over its block­buster Tec­fidera patent

John Carroll

Editor & Founder

The rough road Bio­gen has been trav­el­ing dur­ing the first half of 2020 just got con­sid­er­ably more bumpy.

A fed­er­al judge has ruled that Bio­gen …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times